Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia
Language English Country United States Media print-electronic
Document type Letter
Grant support
The National Institute for Cancer Research Project (Programme EXCELES, ID Project No. LX22NPO5102
The CzEch Leukemia Study Group for Life, CELL
PubMed
39873232
DOI
10.1002/ajh.27608
Knihovny.cz E-resources
- Keywords
- additional chromosomal abnormalities, chronic myeloid leukemia, cytogenetics, prognosis,
- MeSH
- Chromosome Aberrations * MeSH
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive * genetics mortality diagnosis MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Chromosomes, Human, Pair 9 genetics MeSH
- Adolescent MeSH
- Disease-Free Survival MeSH
- Prognosis MeSH
- Aged MeSH
- Translocation, Genetic * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Letter MeSH
The influence of t(v;22) sole, major route ACAs all (+8, n = 14; +Ph, n = 10; +19, n = 1), and -Y sole on progression-free survival. Survival curves are compared with those of patients with the standard t(9;22) translocation. Other ACAs or complex karyotypes did not influence survival.
Department of Hemato Oncology University Hospital Ostrava Ostrava Czech Republic
Department of Hematology and Oncology University Hospital Plzeň Plzeň Czech Republic
Department of Hematology Oncology University Hospital Olomouc Olomouc Czech Republic
Department of Hematology University Hospital Královské Vinohrady Praha Czech Republic
Department of Internal medicine Hematology General University Hospital Praha Czech Republic
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Health Information and Statistics of the Czech Republic Praha Czech Republic
Institute of Hematology and Blood Transfusion Praha Czech Republic
References provided by Crossref.org